Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2026)

Camp4 Therapeutics has reported Retained Earnings for 4 years, with the latest figure at -$310.5 million in Q1 2026.

• Quarterly Retained Earnings fell 38.49% year-over-year to -$310.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$310.5 million (down 38.49% YoY) and the FY2025 annual result came in at -$292.2 million, down 37.97% from the prior year.
• Retained Earnings slipped to -$310.5 million in Q1 2026 per CAMP's latest filing, from -$292.2 million in the prior quarter.
• Over five years, Retained Earnings peaked at $36.2 million in Q4 2023 and troughed at -$310.5 million in Q1 2026.
• A 4-year average of -$211.2 million and a median of -$230.5 million in 2025 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 684.45% in 2024, then decreased 26.9% in 2025.
• Over 4 years, Retained Earnings stood at $36.2 million in 2023, then sank by 684.45% to -$211.8 million in 2024, then slumped by 37.97% to -$292.2 million in 2025, then declined by 6.28% to -$310.5 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$310.5 million, -$292.2 million, and -$251.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.